David Huss

David Huss is the CSO at ShapeTX. Prior to that, they were the Associate Director of Early Pipeline Research at Juno Therapeutics from February 2016 to November 2018. David has also worked as a Scientist and Discovery Project Lead for Immunology Research at Biogen from June 2011 to February 2016. David was also a Graduate Research Fellow at The Ohio State University Wexner Medical Center from September 2007 to June 2011. Prior to that, David worked as a Pharmaceutical Sales Representative for Eli Lilly and Company's Neuroscience Sales and Marketing Division from February 2006 to September 2007.

David Huss began their educational career by earning a Bachelor of Arts in Biology from Cedarville University. David then went on to earn a PhD in Molecular, Cellular and Developmental Biology from The Ohio State University.

David Huss works with Will Krause - VP, Finance, Ron Hause - VP, Head of Analytics and Informatics, and Rafael Ponce - EVP, Preclinical Development. Their manager is Francois Vigneault, Co-Founder, President & CEO.